Net profit of Syncom Formulations (India) rose 69.08% to Rs 7.00 crore in the quarter ended December 2023 as against Rs 4.14 crore during the previous quarter ended December 2022. Sales rose 13.52% to Rs 65.14 crore in the quarter ended December 2023 as against Rs 57.38 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales65.1457.38 14 OPM %11.2810.28 - PBDT10.837.17 51 PBT9.385.97 57 NP7.004.14 69 Powered by Capital Market - Live News

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company on 14 February 2024.Powered by Capital Market - Live News

Net profit of Syncom Formulations (India) rose 81.34% to Rs 6.51 crore in the quarter ended September 2023 as against Rs 3.59 crore during the previous quarter ended September 2022. Sales rose 17.16% to Rs 63.84 crore in the quarter ended September 2023 as against Rs 54.49 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales63.8454.49 17 OPM %10.037.87 - PBDT9.336.54 43 PBT8.455.36 58 NP6.513.59 81 Powered by Capital Market - Live News

Syncom Formulations (India) will hold a meeting of the Board of Directors of the Company on 8 November 2023.Powered by Capital Market - Live News

Syncom Formulations (India) announced that the Annual General Meeting (AGM) of the company will be held on 26 September 2023.Powered by Capital Market - Live News